Influencing Factors and Intervention Strategies for Psychological Insulin Resistance in Community-Based Patients with Diabetes Receiving Insulin Therapy

Jingjing Wang

doi:10.54097/x5nt9y30

Authors

Jingjing Wang

DOI:

https://doi.org/10.54097/x5nt9y30

Keywords:

Psychological Insulin Resistance, Insulin Therapy Reluctance, Type 2 Diabetes Mellitus, Influencing Factors, Community, Health Education

Abstract

Psychological Insulin Resistance (PIR) is a major psychological barrier for community-dwelling patients with type 2 diabetes mellitus to initiate and maintain insulin therapy, manifesting as difficulties in treatment initiation, injection-related fear and anxiety, disease cognition and belief biases, and psychosocial distress. PIR is influenced by multiple factors: at the patient level, including sociodemographic characteristics, personality traits, and health literacy; at the disease and treatment level, involving the complexity of treatment regimens; at the social environment level, encompassing family support and sociocultural factors; and at the iatrogenic and health system level, relating to the quality of physician-patient communication and accessibility of healthcare resources. Assessment tools include the Insulin Treatment Appraisal Scale (ITAS), the Hypoglycemia Fear Survey (HFS), and the Diabetes Distress Scale (DDS). Community-based intervention strategies should integrate behavioral change techniques (motivational interviewing, cognitive behavioral therapy, empowerment education), construct social support systems (family support, peer support), and optimize service models (shared decision-making, information technology, simplified treatment regimens). Future research should explore the integration of psychological interventions into family doctor contract services to improve the quality of community diabetes management.

Downloads

Download data is not yet available.

References

[1] Jiang H, Zhang L, Wang Y, et al. Influencing factors of psychological insulin resistance among patients with type 2 diabetes: a systematic review and meta-analysis. Journal of Diabetes & Metabolic Disorders. 2025;24(2):201. doi:10.1007/ s40200-025-01714-5.

[2] Wu Y, Xu H, Wang Y, et al. The impact of psychological insulin resistance and dyadic coping on insulin medication adherence in elderly diabetes patients and their spouses: a latent profile analysis. Patient Preference and Adherence. 2024;18:2647–2655. doi:10.2147/PPA.S492722.

[3] Hosomura N, Malmasi S, Timerman D, et al. Decline of insulin therapy and delays in insulin initiation in people with uncontrolled diabetes mellitus. Diabetic Medicine. 2017;34 (11): 1599–1602. doi:10.1111/dme.13454.

[4] Gherman A, Veresiu IA, Sassu RA, et al. Psychological insulin resistance: a critical review of the literature. Practical Diabetes International. 2011;28(3):125–128. doi:10.1002/pdi.1574.

[5] Xing W. Correlation between stigma and psychological insulin resistance in patients with diabetes [Dissertation]. Guangzhou: Jinan University; 2020. doi:10.27167/d.cnki. gjinu. 2020. 00 2012.

[6] Peyrot M, Rubin RR, Kruger DF, et al. Correlates of insulin injection omission. Diabetes Care. 2010;33(2):240–245. doi:10. 2337/dc09-1348.

[7] Hermanns N, Mahr M, Kulzer B, et al. Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study. Diabetes Stoffwechsel und Herz. 2015; 24: 137–144.

[8] Frid A, Hirsch L, Gaspar R, et al. New injection recommendations for patients with diabetes. Diabetes Therapy. 2017; 8(4):673–682. doi:10.1007/s13300-017-0284-y.

[9] Nam S, Chesla C, Stotts NA, et al. Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diabetes Care. 2010;33(8):1747–1749. doi:10.2337/ dc10-0099.

[10] Brod M, Kongsø JH, Lessard S, et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Quality of Life Research. 2009;18(1):23–32. doi:10.1007/s11136-008-9419-1.

[11] Chen J. Correlation between stigma and psychological insulin resistance in patients with type 2 diabetes [Dissertation]. Wuhan: Wuhan Polytechnic University; 2022. doi:10.27776/ d. cnki. gwhgy.2022.000306.

[12] Li H. Correlation between psychological insulin resistance and self-efficacy in patients with type 2 diabetes [Dissertation]. Wuhan: Wuhan Polytechnic University; 2019. doi:10.27776/ d. cnki. gwhgy.2019.000066.

[13] Karter AJ, Subramanian U, Saha C, et al. Barriers to insulin initiation: the Translating Research Into Action for Diabetes Insulin Starts Project. Diabetes Care. 2010;33(4):733–735. doi:10.2337/dc09-1184.

[14] International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels: International Diabetes Federation; 2019.

[15] Niu XM, Yang L. Current status and influencing factors of psychological insulin resistance in patients with type 2 diabetes. Chinese Journal of Practical Nursing. 2014;30(4):39–42. doi: 10.3969/j.issn.1006-6187.2011.04.005.

[16] Gao YX, Li H, Wang L. Investigation of psychological insulin resistance in patients with type 2 diabetes in Fangshan District, Beijing. Chinese Journal of Diabetes. 2011;19(4):257–259. doi: 10. 3969/j.issn.1006-6187.2011.04.005.

[17] Polonsky WH, Fisher L, Guzman S, et al. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005;28(10):2543–2545. doi:10.2337/ diacare. 28.10.2543.

[18] Batais MA, Schantter P. Prevalence of unwillingness to use insulin therapy and its associated attitudes among patients with type 2 diabetes in Saudi Arabia. Primary Care Diabetes. 2016; 10 (6): 415–424. doi: 10.1016/j.pcd.2016.05.007.

[19] Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. Journal of General Internal Medicine. 2012;27(10):1361–1367. doi:10.1007/s11606-012-2077-6.

[20] Zhang S, Zhang X, Wang H, et al. Factors associated with psychological insulin resistance among patients with type 2 diabetes in China. Frontiers in Endocrinology. 2024;15: 1368132. doi:10.3389/fendo.2024.1368132.

[21] Holmes-Truscott E, Pouwer F, Speight J. Assessing psychological insulin resistance in type 2 diabetes: a critical comparison of measures. Current Diabetes Reports. 2017;17(7): 46. doi:10.1007/s11892-017-0873-4.

[22] Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes: development of the Diabetes Distress Scale. Diabetes Care. 2005;28(3):626–631. doi:10.2337/ diacare. 28. 3. 626.

[23] Petrak F, Stridde E, Leverkus F, et al. Development and validation of a new measure to assess psychological insulin resistance: the Insulin Treatment Appraisal Scale (ITAS). Diabetes Care. 2007;30(8):2023–2025. doi:10.2337/dc06-2272.

[24] Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. New York: Guilford Press; 2013.

[25] Hermanns N, Kulzer B, Ehrmann D, et al. The effect of a diabetes education programme (PRIMAS) for people with type 1 diabetes: results of a randomized trial. Diabetes Research and Clinical Practice. 2013;102(3):149–157. doi:10.1016/j. diabres. 2013. 10.005.

[26] Song Y, Lee K, Kim M, et al. The prevalence of insulin refusal and psychological insulin resistance among Korean patients with type 2 diabetes mellitus. Annals of Translational Medicine. 2019;7(23):760. doi:10.21037/atm.2019.11.77.

[27] Kruger DF, LaRue S, Estep J. Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2015; 8:49–56. doi:10.2147/DMSO.S71923.